Sex Characteristic Change Treatment Amendments, the official text

Sex Characteristic Change Treatment Amendments
2026 GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Rex P. Shipp
Senate Sponsor: Daniel McCay

LONG TITLE
General Description:
This bill amends provisions related to the provision of cross-sex hormones and puberty blockers to minors.
Highlighted Provisions:
This bill: prohibits providing cross-sex hormones and puberty blockers to minors after a certain date.

Money Appropriated in this Bill: None Other Special Clauses: This bill provides a special effective date. This bill provides revisor instructions. Utah Code Sections Affected: AMENDS:
58-1-603.1, as enacted by Laws of Utah 2023, Chapter 2 and further amended by Revisor Instructions, Laws of Utah 2023, Chapter 2

REPEALS:
26B-1-239, as last amended by Laws of Utah 2024, Chapter 507

Be it enacted by the Legislature of the state of Utah:
The following section is affected by a revisor instruction at the end of this bill. Section 1. Section 58-1-603.1 is amended to read:
58-1-603.1. Hormonal transgender treatment prohibition for minors.
(1) As used in this section: (a) "Cross-sex hormone treatment" means administering, prescribing, or supplying for effectuating or facilitating an individual's attempted sex change: (i) to an individual whose biological sex at birth is female, a dose of testosterone or other androgens at levels above those normally found in an individual whose biological sex at birth is female; or
(ii) to an individual whose biological sex at birth is male, a dose of estrogen or a synthetic compound with estrogenic activity or effect at levels above those normally found in an individual whose biological sex at birth is male.

(b) "Health care provider" means the same as that term is defined in Section 58-1-603.
[(b)] (c) "Hormonal transgender treatment" means the same as that term is defined in Section 58-1-603.
(d) "Minor" means the same as that term is defined in Section 58-1-603.

(2) [A] Subject to Subsection (3), a health care provider may not provide a hormonal transgender treatment to a patient who: (a) is a minor[as defined in Section 58-1-603]; and
(b) is not diagnosed with gender dysphoria before January 28, 2023.

(3) Notwithstanding Subsection 58-1-603(3)(a), beginning on January 28, 2027, a health care provider may not provide a hormonal transgender treatment to a patient who is a minor if the patient: (a) would be younger than 16 years old as of the effective date of this bill; or
(b) has not received cross-sex hormones as of the effective date of this bill.

(4) A health care provider who provides hormonal transgender treatment to a minor for the purpose of discontinuing treatment before January 28, 2027, may provide the treatment without obtaining a transgender treatment certification described in Section 58-1-603.
[(3)] (5) A violation of Subsection (2) or (3) is unprofessional conduct.

Section 2. Repealer.
Systematic medical evidence review of hormonal transgender treatments.
Section 3. Effective Date.
This bill takes effect: (1) except as provided in Subsection (2), May 6, 2026; or
(2) if approved by two-thirds of all members elected to each house: (a) upon approval by the governor;
(b) without the governor's signature, the day following the constitutional time limit of Utah Constitution, Article VII, Section 8; or
(c) in the case of a veto, the date of veto override.

Section 4. Revisor instructions.
The Legislature intends that the Office of Legislative Research and General Counsel, in preparing the Utah Code database for publication, to revise Section 58-1-603.1 by replacing each instance of the phrase "the effective date of this bill" with the bill's actual effective date.

2-26-26 7:45 PM